BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 16, 2010
View Archived Issues
Memory Pharmaceuticals claims novel 5-HT6 receptor ligands
Read More
Novel MIF inhibitors identified by Yale University scientists for cancer therapy
Read More
Phase II data support superiority of OvPlex to CA-125 for diagnosis ovarian cancer
Read More
Array BioPharma claims novel Pim kinase inhibitors
Read More
GlaxoSmithKline presents new interferon inducers
Read More
Schering-Plough and Southern Research Institute claim new antivirals
Read More
Sirtris Pharmaceuticals presents novel SIRT modulators
Read More
Amgen patents novel Na(V)1.7 sodium channel blockers
Read More
Cilostazol may benefit patients with acute ischemic stroke
Read More
Array Biopharma presents new D2 receptor antagonists for allergic disease
Read More
Paricalcitol improves albuminuria in diabetic nephropathy
Read More
Eisai and Johns Hopkins to collaborate on development GCPII inhibitors
Read More
Xoma initiates phase II trial of XOMA-052 in type 1 diabetes
Read More
FDA grants orphan drug status to BioSante's GVAX pancreatic cancer vaccine
Read More
Inspire Pharmaceuticals reports phase II data on Azasite for blepharitis
Read More
Savient resubmits Krystexxa BLA for chronic gout to FDA
Read More
FDA requests additional information regarding Afrezza NDA for hyperglycemia in diabetes
Read More
MicuRx files IND for MRX-I antibiotic in China
Read More
UCB presents full-year results 2009
Read More
Amylin, Lilly and Alkermes receive FDA's complete response letter on once-weekly exenatide
Read More
Bio-Path receives FDA approval for clinical evaluation liposomal Grb-2 in cancer
Read More
FDA adds boxed warning to Plavix for reduced effectiveness in poor metabolizers of the drug
Read More
Revolade approved in Europe for thrombocytopenia in ITP
Read More
Orexigen and Patheon enter into exclusive manufacturing agreement for Contrave
Read More
Sigma-Aldrich to sell Pfizer's small-molecule compounds to researchers
Read More
